D. Hamel

发表

Limit of Detection for Rapid Antigen Testing of the SARS-CoV-2 Omicron and Delta Variants of Concern Using Live-Virus Culture

R. Arnaout, J. Kirby, S. Riedel, 2022, Journal of clinical microbiology.

Limit of Detection for Rapid Antigen Testing of the SARS-CoV-2 Omicron Variant

S. Riedel, J. Kirby, A. Cheng, 2022, medRxiv.

Sustained Specific and Cross-Reactive T Cell Responses to Zika and Dengue Virus NS3 in West Africa

S. Mboup, Wei-Kung Wang, P. Kanki, 2018, Journal of Virology.

Sars-Cov-2 antigen tests predict infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large sample cohort

R. Arnaout, S. Riedel, J. Kirby, 2021, Clinical Microbiology and Infection.

Short communication: Transmitted HIV drug resistance in antiretroviral-naive pregnant women in north central Nigeria.

J. Sankalé, J. Musa, P. Kanki, 2014, AIDS research and human retroviruses.

HIV‐1 and HIV‐2 dual infection: lack of HIV‐2 provirus correlates with low CD4+ lymphocyte counts

I. Thior, S. Mboup, M. Essex, 1998, AIDS.

High SARS-CoV-2 seroprevalence in Lagos, Nigeria with robust antibody and cellular responses

A. Osibogun, F. Ogunsola, B. B. Herrera, 2022, medRxiv.

Twenty years of prospective molecular epidemiology in Senegal: changes in HIV diversity.

S. Mboup, J. Sankalé, P. Kanki, 2007, AIDS research and human retroviruses.

Expression of HIV-1 in the cerebrospinal fluid detected by the polymerase chain reaction and its correlation with central nervous system disease.

R. Miller, M. Harrison, R. Tedder, 1991, AIDS.

The level of APOBEC3G (hA3G)-related G-to-A mutations does not correlate with viral load in HIV type 1-infected individuals.

S. Mboup, J. Sankalé, Nzovu K Ulenga, 2008, AIDS research and human retroviruses.

Interaction with human immunodeficiency virus (HIV) type 2 predicts HIV type 1 genotype.

S. Mboup, J. Sankalé, M. Essex, 2000, Virology.

Human immunodeficiency virus type 1 subtypes differ in disease progression.

I. Thior, C. Hsieh, S. Mboup, 1999, The Journal of infectious diseases.

A modified anthrax toxin-based enzyme-linked immunospot assay reveals robust T cell responses in symptomatic and asymptomatic Ebola virus exposed individuals

C. Happi, Onikepe O Folarin, P. Kanki, 2018, PLoS neglected tropical diseases.

Distinct Human Immunodeficiency Virus Type 1 Subtype A Virus Circulating in West Africa: Sub-Subtype A3

F. McCutchan, S. Mboup, J. Sankalé, 2004, Journal of Virology.

Building laboratory capacity to support HIV care in Nigeria: Harvard/APIN PEPFAR, 2004–2012

J. Sankalé, P. Kanki, A. Sarr, 2015, African journal of laboratory medicine.

Molecular Epidemiology of Human Immunodeficiency Virus Type 1 Sub-Subtype A3 in Senegal from 1988 to 2001

S. Mboup, J. Sankalé, P. Kanki, 2004, Journal of Virology.

The Coviral Portal: Multi-Cohort Viral Loads and Antigen-Test Virtual Trials for COVID-19

R. Arnaout, M. Yasuda, S. Riedel, 2023, medRxiv.

HIV type 1 circulating recombinant form CRF09_cpx from west Africa combines subtypes A, F, G, and may share ancestors with CRF02_AG and Z321.

Sodsai Tovanabutra, D. Birx, F. McCutchan, 2004, AIDS research and human retroviruses.

Molecular evolution of human immunodeficiency virus type 1 subtype A in Senegal: 1988-1997.

M. Essex, P. Kanki, A. Guéye-Ndiaye, 2000, Journal of human virology.

Relation between HIV-2 proviral load and CD4+ lymphocyte count differs in monotypic and dual HIV infections.

S. Popper, I. Thior, S. Mboup, 1999, Journal of Human Virology.

Chikungunya virus antepartum transmission and abnormal infant outcomes in Nigeria

H. Furuya, Wei-Kung Wang, P. Kanki, 2023, medRxiv.

High SARS-CoV-2 seroprevalence in Lagos, Nigeria with robust antibody and cellular immune responses

S. Ogunsola, P. Kanki, A. Osibogun, 2023, Journal of Clinical Virology Plus.

Arbovirus surveillance in pregnant women in north-central Nigeria, 2019-2022

M. Paul, Wei-Kung Wang, P. Kanki, 2023, medRxiv.